Covered recipient · General Payments record
MITAL GANDHI
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2023
$224.85
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $224.85 | 15 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $45.64 | 3 |
| Tris Pharma Inc | $31.75 | 2 |
| PFIZER INC. | $30.18 | 2 |
| Corium, Inc. | $21.23 | 2 |
| SANOFI PASTEUR INC. | $20.52 | 1 |
| GlaxoSmithKline, LLC. | $17.00 | 1 |
| Seqirus USA Inc | $17.00 | 1 |
| Kaleo, Inc. | $15.09 | 1 |
| Cumberland Pharmaceuticals, Inc. | $13.45 | 1 |
| AYTU BioPharma, Inc. | $12.99 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2023 | $224.85 | 15 |
Payment records · PY2023 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aytu BioPharma, Inc. | $12.99 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 981722417 | CMS |
| Corium, LLC | $14.35 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978146861 | CMS |
| Corium, LLC | $6.88 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 978296923 | CMS |
| Cumberland Pharmaceuticals, Inc. | $13.45 | 03/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052115805 | CMS |
| GlaxoSmithKline, LLC. | $17.00 | 05/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002622231 | CMS |
| kaleo, Inc. | $15.09 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1013052579 | CMS |
| Merck Sharp & Dohme LLC | $15.56 | 03/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048861135 | CMS |
| Merck Sharp & Dohme LLC | $13.23 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048335769 | CMS |
| Merck Sharp & Dohme LLC | $16.85 | 07/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048738109 | CMS |
| PFIZER INC. | $15.94 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049383959 | CMS |
| PFIZER INC. | $14.24 | 07/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049877797 | CMS |
| SANOFI PASTEUR INC. | $20.52 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1044021769 | CMS |
| Seqirus USA Inc | $17.00 | 08/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1021362373 | CMS |
| Tris Pharma Inc | $16.93 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059353689 | CMS |
| Tris Pharma Inc | $14.82 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059353717 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023
- Source files
- Dataset page · Bulk file · PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.